% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Siegert:155735,
author = {Siegert, Anna and Rankovic, Marija and Favretto, Filippo
and Ukmar-Godec, Tina and Strohäker, Timo and Becker,
Stefan and Zweckstetter, Markus},
title = {{I}nterplay between tau and α-synuclein liquid-liquid
phase separation.},
journal = {Protein science},
volume = {30},
number = {7},
issn = {1469-896X},
address = {Bethesda, Md.},
publisher = {Protein Society},
reportid = {DZNE-2021-00903},
pages = {1326 - 1336},
year = {2021},
abstract = {In Parkinson's disease with dementia, up to $50\%$ of
patients develop a high number of tau-containing
neurofibrillary tangles. Tau-based pathologies may thus act
synergistically with the α-synuclein pathology to confer a
worse prognosis. A better understanding of the relationship
between the two distinct pathologies is therefore required.
Liquid-liquid phase separation (LLPS) of proteins has
recently been shown to be important for protein aggregation
involved in amyotrophic lateral sclerosis, whereas tau phase
separation has been linked to Alzheimer's disease. We
therefore investigated the interaction of α-synuclein with
tau and its consequences on tau LLPS. We find α-synuclein
to have a low propensity for both, self-coacervation and
RNA-mediated LLPS at pH 7.4. However, full-length but not
carboxy-terminally truncated α-synuclein efficiently
partitions into tau/RNA droplets. We further demonstrate
that Cdk2-phosphorylation promotes the concentration of tau
into RNA-induced droplets, but at the same time decreases
the amount of α-synuclein inside the droplets. NMR
spectroscopy reveals that the interaction of the
carboxy-terminal domain of α-synuclein with the
proline-rich region P2 of tau is required for the
recruitment of α-synuclein into tau droplets. The combined
data suggest that the concentration of α-synuclein into
tau-associated condensates can contribute to synergistic
aSyn/tau pathologies.},
keywords = {Alzheimer Disease: metabolism / Amyotrophic Lateral
Sclerosis: metabolism / Humans / Recombinant Proteins:
chemistry / Recombinant Proteins: isolation $\&$
purification / Recombinant Proteins: metabolism /
alpha-Synuclein: chemistry / alpha-Synuclein: isolation $\&$
purification / alpha-Synuclein: metabolism / tau Proteins:
chemistry / tau Proteins: isolation $\&$ purification / tau
Proteins: metabolism / LLPS (Other) / phosphorylation
(Other) / tau (Other) / truncation (Other) / α-synuclein
(Other)},
cin = {AG Zweckstetter / Göttingen common},
ddc = {610},
cid = {I:(DE-2719)1410001 / I:(DE-2719)6000014},
pnm = {352 - Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33452693},
pmc = {pmc:PMC8197422},
doi = {10.1002/pro.4025},
url = {https://pub.dzne.de/record/155735},
}